Medication adherence: the invisible lever with outsized impact

A prescription the patient never takes correctly is not a treatment. It is a hope with a signature on it, and the distance between the two is where a great deal of ordinary medicine quietly fails.

This article is about what happens after the patient stands up: where the instruction goes, how much survives the walk to the pharmacy, and which parts a practice management system can carry. On what a practitioner owes a patient in follow-up, the reference that binds is the professional one, not a vendor's. What follows is mechanism.

The line that reframed a field

Adherence used to be filed under patient behaviour — a matter of willingness, discussed in the last ninety seconds of a visit and rarely measured. One report moved it, and its central finding is quoted in full below.

Read carefully, that finding is a claim about systems, not about patients. It says the return on making an existing treatment reliably taken can exceed the return on inventing a better one. It relocates the problem from the patient's character to the design of everything around the prescription: how the instruction is delivered, whether it is legible later, whether anyone notices when it lapses.

Where it actually breaks

Adherence rarely fails in one dramatic moment. It fails in four ordinary places, and each of them is a place where information was spoken rather than recorded.

The first is the end of the consultation. The instruction that matters most — take this one at night, stop the other after ten days, come back if this happens — is delivered when attention is lowest, by a doctor already thinking about the next patient and a patient already reaching for their bag. Nothing about it is written in a form the patient can consult at nine that evening.

The second is the paper. A handwritten sheet is a single point of failure: folded, carried, lost, or misread at the pharmacy counter. In Doctopass, digital prescriptions are signed with SHA-256 and carry a QR-verified PDF, on every plan — the same clinical decision in a form that survives the week.

The third is the lapse nobody sees. A course abandoned in week two looks identical, from inside the practice, to a course completed. No event, no message, no line in a file — and the next consultation begins on an assumption.

The fourth is the second prescriber. A patient who sees a specialist between visits comes back carrying a medication the original record does not know about. A safety check is only as good as the list it reads, which is why drug interaction checking is worth running against one record rather than four — the reasoning set out in preventable medication errors.

What the software carries

Software cannot make a patient take a tablet. What it can do is remove the three failure modes that are purely informational: the instruction that was never written down, the reminder that was never sent, and the list that was never shared.

Structured post-visit care plans turn the closing ninety seconds into a record the patient can open later, with reminders attached. The trilingual portal makes that plan legible in the language the patient actually reads — a point developed in language barriers and patient safety. Family and caregiver shared access, on every plan, puts it in front of whoever manages the medicine at home, who is frequently not the patient; the practice management platform page shows how the portal and the record sit together.

Two rows set the honest boundary. Reminders reach every plan by push and in-app, but the SMS and WhatsApp credits that reach a patient who never opens the app are bundled from Pro and are an add-on on Essential; structured care plans start at Pro. We would rather write that gate down than let it be discovered after signature.

What we will not publish

Two things, and both are refusals of the kind of number that sells software.

We will not publish an adherence rate you should expect. The figure that would matter is the one in your own practice, and no vendor has it. The arithmetic is yours to run: take one chronic cohort, count how many are still collecting the medicine at month six, and hold that number as your baseline before you change anything.

Nor will we state what follow-up a clinician is obliged to provide, or how long a treatment record must be kept. Those are questions for the binding professional and regulatory authorities. What we describe is the mechanism the software runs — the record, the plan, the reminder, the trail.

Frequently asked

Does Doctopass track whether a patient took their medicine?

No, and no software honestly can. What it records is what was prescribed, what plan was issued, what reminders went out and what the patient sent back through the portal. Everything past that is inference, and we will not dress inference up as measurement.

Which reminders reach a patient who never opens the app?

SMS and WhatsApp. Push and in-app reminders are on all three plans, but they require the app; the SMS and WhatsApp credits that reach everyone else are bundled at 200 a month on Pro and 500 on Premium, and can be added to Essential. Credits can be topped up on any plan.

Which plan do I need for structured care plans?

Pro, at 159 DT. Essential, at 69 DT, carries the record, the portal, prescriptions and push reminders, but not the post-visit care plan; Premium, at 269 DT, adds the larger message allowance. Per doctor, per month, billed annually, after a fourteen-day trial; the row-by-row comparison is on the pricing page.

The most powerful intervention in most consultations is not a new drug. It is making sure the current one is taken as written — a documentation problem before it is a clinical one. To see the care plan, the portal and the prescription working on one record, request a 30-minute demo and bring a chronic case you already follow.